Viatris (VTRS) Other Operating Expenses (2019 - 2026)
Viatris (VTRS) posted quarterly Other Operating Expenses of -$53.5 million for Q1 2026, down 172.79% year-over-year from $73.5 million in Q1 2025, and down 1825.81% quarter-over-quarter from $3.1 million in Q4 2025.
Viatris (VTRS) Other Operating Expenses (2019 - 2026) Analysis & Trends
Viatris' Other Operating Expenses history runs 8 years deep, the most recent figure standing at -$53.5 million for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 172.79% year-over-year to -$53.5 million; the TTM figure through Mar 2026 stood at -$58.5 million (up 70.84% YoY), while the FY2025 annual figure was $68.5 million, up 119.52% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$53.5 million, down from $3.1 million in the prior quarter.
- The five-year high for Other Operating Expenses was $73.5 million in Q1 2025, with the low at -$148.1 million in Q4 2023.
- The 5-year median for Other Operating Expenses is -$6.2 million (2022), against an average of -$26.6 million.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses jumped 569.23% in 2023, then plunged 12700.0% in 2024.
- Viatris' Other Operating Expenses stood at $8.8 million in 2022, then plunged by 1782.95% to -$148.1 million in 2023, then advanced by 24.65% to -$111.6 million in 2024, then jumped by 102.78% to $3.1 million in 2025, then slumped by 1825.81% to -$53.5 million in 2026.
- Business Quant data shows VTRS's Other Operating Expenses at -$53.5 million in Q1 2026, $3.1 million in Q4 2025, and -$55.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -73.20 Mn |
| Mar 31, 2026 | -53.50 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Sep 30, 2025 | -55.70 Mn |
| Jun 30, 2025 | 47.60 Mn |
| Mar 31, 2025 | 73.50 Mn |
| Dec 31, 2024 | -111.60 Mn |
| Sep 30, 2024 | -31.50 Mn |
| Jun 30, 2024 | -131.00 Mn |
| Mar 31, 2024 | -76.80 Mn |
| Dec 31, 2023 | -148.10 Mn |
| Sep 30, 2023 | 26.10 Mn |
| Jun 30, 2023 | 11.00 Mn |
| Mar 31, 2023 | -600,000.00 |
| Dec 31, 2022 | 8.80 Mn |
| Sep 30, 2022 | 3.90 Mn |
| Jun 30, 2022 | -10.90 Mn |
| Mar 31, 2022 | -6.20 Mn |
| Dec 31, 2021 | -273.90 Mn |
| Sep 30, 2021 | -9.40 Mn |